AQP7 and obesity disorder: Since catecholamines and insulin stimulate and inhibit PKA, respectively [161], it was suggested that the AQP7–PLIN1 interaction may play a key role in triacylglycerol metabolism under physiological conditions as well as in metabolic diseases such as obesity (Figure 5B).